Video
Author(s):
Drs Singal and Lewandowski review use of tyrosine kinase inhibitors, sorafenib and lenvatinib, and discuss trials that combined systemic therapy with chemoembolization.
Fecal Microbiota Transplants May Enhance Immunotherapy Efficacy in GI Cancers
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Complexity in GI Cancer: Questions Are Answered in Gastroesophageal Cancer, Remain in HCC
D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor
Innovative Research Continues to Propel Individualized GIST Treatments
FDA Approval Sought for Another Formulation of Lutetium Lu 177 Dotatate in SSTR+ GEP-NETs
Dr Sands on the Evolving Role of ADCs in SCLC Management
Dr Hirsch on the Treatment of NRG1 Fusion+ NSCLC
MRD Testing Requires Prospective Data to Assess Clinical Utility in Breast Cancer
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes